![Invitrogen™ eBioscience™ Anti-Human CD3 Super Bright 600 Clone: OKT3 Antibody by Thermo Fisher Scientific LSG - Protein & Cell Analysis - Flow - Antibodies & Immunoassays Invitrogen™ eBioscience™ Anti-Human CD3 Super Bright 600 Clone: OKT3 Antibody by Thermo Fisher Scientific LSG - Protein & Cell Analysis - Flow - Antibodies & Immunoassays](http://selectscience.net/images/products/63-0037-42-CD3-Flow-20170216130641.jpg)
Invitrogen™ eBioscience™ Anti-Human CD3 Super Bright 600 Clone: OKT3 Antibody by Thermo Fisher Scientific LSG - Protein & Cell Analysis - Flow - Antibodies & Immunoassays
![Frontiers | The Affinity of Elongated Membrane-Tethered Ligands Determines Potency of T Cell Receptor Triggering Frontiers | The Affinity of Elongated Membrane-Tethered Ligands Determines Potency of T Cell Receptor Triggering](https://www.frontiersin.org/files/Articles/268171/fimmu-08-00793-HTML/image_m/fimmu-08-00793-g001.jpg)
Frontiers | The Affinity of Elongated Membrane-Tethered Ligands Determines Potency of T Cell Receptor Triggering
![A) Schematic representation of the expression cassettes for anti-CD3... | Download Scientific Diagram A) Schematic representation of the expression cassettes for anti-CD3... | Download Scientific Diagram](https://www.researchgate.net/publication/8778088/figure/fig1/AS:702295004172290@1544451585790/A-Schematic-representation-of-the-expression-cassettes-for-anti-CD3-scFv-constructs.png)
A) Schematic representation of the expression cassettes for anti-CD3... | Download Scientific Diagram
![EP0700402B1 - Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies - Google Patents EP0700402B1 - Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies - Google Patents](https://patentimages.storage.googleapis.com/a4/0e/ce/bddcaa1283286e/00880001.png)
EP0700402B1 - Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies - Google Patents
![EP0700402B1 - Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies - Google Patents EP0700402B1 - Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies - Google Patents](https://patentimages.storage.googleapis.com/d7/70/bf/3429f996809c15/00860001.png)
EP0700402B1 - Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies - Google Patents
![Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3 | PNAS Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3 | PNAS](https://www.pnas.org/cms/10.1073/pnas.0402295101/asset/c4455f50-eaad-489f-8f02-ec435d5357c8/assets/graphic/zpq0200448390002.jpeg)
Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3 | PNAS
![T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites by Shigeto Yoshida, - ppt download T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites by Shigeto Yoshida, - ppt download](https://slideplayer.com/slide/15018805/91/images/2/The+nucleotide+and+deduced+amino-acid+sequences+of+5.+2-OKT3+biscFv.jpg)
T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites by Shigeto Yoshida, - ppt download
![Scheme of a recombinant OKT3 scFv IgM monomer. scOKT3-γ ΔIgM constructs... | Download Scientific Diagram Scheme of a recombinant OKT3 scFv IgM monomer. scOKT3-γ ΔIgM constructs... | Download Scientific Diagram](https://www.researchgate.net/profile/Tove_Olafsen2/publication/12161723/figure/fig6/AS:267735041048613@1440844416885/Scheme-of-a-recombinant-OKT3-scFv-IgM-monomer-scOKT3-gDIgM-constructs-assemble-via_Q320.jpg)
Scheme of a recombinant OKT3 scFv IgM monomer. scOKT3-γ ΔIgM constructs... | Download Scientific Diagram
![Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia: Molecular Therapy Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia: Molecular Therapy](https://www.cell.com/cms/attachment/d06443c6-728d-42c0-976b-e0441b9fa0da/gr1_lrg.jpg)
Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia: Molecular Therapy
![Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model | Scientific Reports Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-06953-7/MediaObjects/41598_2022_6953_Fig1_HTML.png)
Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model | Scientific Reports
![Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity | Gene Therapy Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fgt.2017.3/MediaObjects/41434_2017_Article_BFgt20173_Fig1_HTML.jpg)